Sequoia Vaccines Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
IPO
- (Cancelled)
- Latest Deal Amount
-
$25M
- Investors
-
5
Sequoia Vaccines General Information
Description
Sequoia Vaccines Inc is a clinical stage pharmaceutical company developing a vaccine designed to prevent recurrent urinary tract infections (UTIs) and small molecules treating cancers and bacterial infections. Its current vaccine SEQ-400, is a vaccine for the prevention of recurrent UTIs.
Contact Information
Website
www.sequoiavaccines.comCorporate Office
- 11775 Borman Drive
- Suite 100
- Saint Louis, MO 63146
- United States
Corporate Office
- 11775 Borman Drive
- Suite 100
- Saint Louis, MO 63146
- United States
Sequoia Vaccines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. IPO | 05-May-2025 | $25M | Cancelled | Clinical Trials - Phase 1 | ||
| 7. Later Stage VC | 30-Dec-2020 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | 01-Feb-2017 | Completed | Clinical Trials - Phase 1 | |||
| 5. Seed Round | 19-May-2016 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC | 30-Nov-2012 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 2. Later Stage VC | 01-Dec-2010 | $389K | $389K | Completed | Clinical Trials - Phase 1 | |
| 1. Grant | 01-Jan-2009 | $1.73M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sequoia Vaccines Comparisons
Industry
Financing
Details
Sequoia Vaccines Competitors (3)
One of Sequoia Vaccines’s 3 competitors is Aclaris Therapeutics, a Formerly VC-backed company based in Wayne, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | ||||
| ArsenalBio | Venture Capital-Backed | South San Francisco, CA | ||||
| Pliant Therapeutics | Formerly VC-backed | San Francisco, CA |
Sequoia Vaccines Patents
Sequoia Vaccines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9562031-B1 | Phenethyldihydrobenzodioxolones and methods of use | Active | 12-Sep-2015 | ||
| WO-2017044877-A1 | Phenethyldihydrobenzodioxolones and methods of use | Inactive | 12-Sep-2015 | ||
| US-20170073324-A1 | Bifidenone compositions and methods of use | Inactive | 11-Sep-2015 | ||
| CA-2923834-A1 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Pending | 17-Mar-2015 | ||
| EP-3069729-A1 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Inactive | 17-Mar-2015 | A61K39/0258 |
Sequoia Vaccines Signals
Sequoia Vaccines Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cultivation Capital | Venture Capital | Minority | ||
| Holton Capital Group | Asset Manager | Minority | ||
| Prolog Ventures | Venture Capital | Minority | ||
| St. Louis Arch Angels | Angel Group | Minority | ||
| U.S. Department of Health and Human Services | Government |
Sequoia Vaccines FAQs
-
When was Sequoia Vaccines founded?
Sequoia Vaccines was founded in 1999.
-
Where is Sequoia Vaccines headquartered?
Sequoia Vaccines is headquartered in Saint Louis, MO.
-
What is the size of Sequoia Vaccines?
Sequoia Vaccines has 5 total employees.
-
What industry is Sequoia Vaccines in?
Sequoia Vaccines’s primary industry is Drug Discovery.
-
Is Sequoia Vaccines a private or public company?
Sequoia Vaccines is a Private company.
-
What is the current valuation of Sequoia Vaccines?
The current valuation of Sequoia Vaccines is .
-
What is Sequoia Vaccines’s current revenue?
The current revenue for Sequoia Vaccines is .
-
How much funding has Sequoia Vaccines raised over time?
Sequoia Vaccines has raised $77.7M.
-
Who are Sequoia Vaccines’s investors?
Cultivation Capital, Holton Capital Group, Prolog Ventures, St. Louis Arch Angels, and U.S. Department of Health and Human Services have invested in Sequoia Vaccines.
-
Who are Sequoia Vaccines’s competitors?
Aclaris Therapeutics, ArsenalBio, and Pliant Therapeutics are competitors of Sequoia Vaccines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process